Mizuho Americas has hired Jason Fertig as Managing Director and Head of Healthcare Investment Banking for its North American banking business. Jason joins Mizuho’s growing North American investment banking franchise with a mandate to develop the firm’s equity, M&A and strategic capital raising advisory capabilities for clients in the healthcare sector, primarily in the specialty pharmaceuticals, biotech, life sciences and emerging medical technology verticals.
In his new role, Fertig will be tasked with leading Mizuho’s healthcare investment banking coverage strategy to drive increased event focused idea generation and deliver the full spectrum of advisory solutions to clients in the Americas, Asia and globally. He will report to John Humphreys, Managing Director and Head of Mizuho’s North American Investment Banking, Advisory and Solutions practice.
“With consolidation activity ongoing throughout the sector, we believe that healthcare will continue to offer tremendous potential opportunities for Mizuho clients on a global basis,” said Humphreys. “Jason’s extensive cross-border and strategic financing transaction expertise, deep sector relationships and strong track record of building successful investment banking teams better positions us to support clients through all phases of the healthcare business lifecycle.”
Fertig joins Mizuho with more than twenty years of investment banking experience advising major pharmaceutical, medical technology and other healthcare sector companies with mergers, acquisitions, divestitures and debt and equity financings.
He previously served as Managing Director and Co-Head of Americas Healthcare Investment Banking for Nomura, where he was responsible for helping to build out the firm’s cross-border M&A and equity/equity-linked financing capability in the US. Prior to Nomura, Fertig headed specialty pharmaceutical investment banking coverage for both Barclays Capital and Lehman Brothers. Fertig holds a Bachelor’s degree from Cornell University and a JD from Columbia University School of Law.
Fertig will be working closely with Reid Hill, who was recently appointed as head of healthcare banking in the Americas, where he will be responsible for managing the bank’s healthcare sector lending and corporate finance-based relationships in the United States.
Fertig’s appointment builds on several recent additions to Mizuho’s growing North American investment banking platform, including Richard Gallivan as Managing Director and Head of Technology Media & Telecom Investment Banking; Chris Nam as Managing Director and Head of Internet and Digital Media Investment Banking; Alok Gupta as Managing Director and Head of Electronics and Hardware Investment Banking, and Brian Carr as Managing Director, Financial Sponsor Coverage.
Mizuho also boasts a strong healthcare equity research platform, with a team of dedicated analysts covering the biotechnology and healthcare services sectors.